An object of the present invention is to provide a fermented milk and polysaccharide capable of inhibiting cancerous cachexia. A fermented milk with cancerous cachexia inhibitory effect according to one aspect of the present invention contains Lactobacillus delbrueckii subsp. bulgaricus as an active ingredient. Also, polysaccharide with cancerous cachexia inhibitory effect according to another aspect of the present invention are produced from the Lactobacillus delbrueckii subsp. bulgaricus. It is preferable that the Lactobacillus delbrueckii subsp. bulgaricus is Lactobacillus delbrueckii subsp. bulgaricus OLL1073R-1 (accession number: FERM BP-10741).

An object of the present invention is to provide a fermented milk and polysaccharide capable of inhibiting cancerous cachexia. A fermented milk with cancerous cachexia inhibitory effect according to one aspect of the present invention contains Lactobacillus delbrueckii subsp. bulgaricus as an active ingredient. Also, polysaccharide with cancerous cachexia inhibitory effect according to another aspect of the present invention are produced from the Lactobacillus delbrueckii subsp. bulgaricus. It is preferable that the Lactobacillus delbrueckii subsp. bulgaricus is Lactobacillus delbrueckii subsp. bulgaricus OLL1073R-1 (accession number: FERM BP-10741).

The invention relates to a method for obtaining low molecular weight heparins which exhibit high stability. The method includes the treatment of depolymerized heparin with H.sub.2O.sub.2 in a ratio of between 0.04 and 1.0 liters of H.sub.2O.sub.2 (30-35% w/v in water) per kg of depolymerized heparin. The invention also relates to a low molecular weight heparin obtained by this method, pharmaceutical compositions of the same, and methods of treatment employing the same.

Disclosed herein are methods for purifying RNA comprising poly A. Also disclosed herein are compositions such as surfaces and oligonucleotides for purifying RNA comprising polyA. Other embodiments are also disclosed. Commercially-available resins having polythymidine oligonucleotide ligands typically contain less than 30 thymidine (2′deoxy) residues and some commercial resin suppliers utilize a distribution of dT chain lengths, not of a discreet length.

Embodiments of the present invention report compositions, systems and methods for obtaining xylo-oligosaccharide-rich extracts from agricultural by-product streams. In certain embodiments, compositions and methods are directed to producing xylo-oligosaccharide-rich extracts with increased amounts and/or concentrations of degrees of polymerization (DP) of 3 or greater (DP3+). In other embodiments, compositions and methods relate to the production of products containing high soluble fiber, for example, xylo-oligosaccharides of DP3 or greater, from oat hull by-products. In yet other embodiments, xylo-oligosaccharides-rich extracts derived from oat hulls can be further processed to generate useful liquids for example, liquids containing soluble solids and powdered sweeteners and other useful consumer products.

The present disclosure relates to systems, methods, and processes for the production of sugars and conversion products from biomass.

An object of the present invention is to provide a method for easily extracting and efficiently recovering xylan from wood.

A xylan-containing material is produced by a method comprising the steps of: (a) adding an acid and/or carbon dioxide to a black liquor discharged during a soda cooking step of wood chips including hardwood chips to adjust the pH of the black liquor to be in the range of 1 to 9, thereby giving a suspension; (b) dehydrating and washing an insoluble matter generated in the suspension to separately collect the insoluble matter; and (c) adding an organic solvent to the insoluble matter obtained at the step (b) to give a suspension, and separately collecting a xylan-containing material made of the insoluble matter present in the suspension by solid/liquid separation.

An industrially scalable process for producing substantially monodisperse compositions of phytoglycogen nanoparticles from phytoglycogen-containing plant materials is provided that avoids the use of chemical, enzymatic or thermo treatments that degrade the phytoglycogen material. Also provided are phytoglycogen nanoparticle compositions produced by these processes.

An ultrasonic extraction equipment includes a solution tank and a plurality of ultrasonic transducers. The ultrasonic transducers are disposed on an outer surface of the solution tank. The ultrasonic transducers include a central ultrasonic transducer and a plurality of peripheral ultrasonic transducers arranged to surround the central ultrasonic transducer.

The invention provides highly concentrated chitosan-nucleic acid polyplex compositions and dispersions, and methods for producing the compositions and dispersions. Methods of mixing the chitosan-nucleic acid polyplexes include an inline mixing of chitosan solution and nucleic acid solution, followed by further concentrating the dispersion of chitosan-nucleic acid polyplexes, optionally with an aggregation inhibitor. Further provides are methods for altering the diameter of chitosan-nucleic acid polyplexes.